Descriptive and Analytical Study of Acute Leukemia in Adults in Eastern Algeria
,
Abstract
Acute leukemia (AL) is a group of malignant hemopathies characterized by monoclonal intramedullary proliferation of abnormal hematopoietic cells, the maturation process of which is blocked at the "Blast" stage. In these pathologies, an abnormal cell clone proliferates. By its character of anarchy, of nonresponse to normal regulators of cell proliferation and its invasive character, this clone assumes all the characters of malignancy. The diagnosis of ALL can no longer be based solely on morphological and cytochemical characteristics, but must include the elements of the immunological phenotype of leukemic cells. Currently, a classification, based on immunophenotypic and cytogenetic data as well as on molecular biology data, is necessary for the determination of the optimal treatment. The objective of this work is to reach a descriptive approach of the acute leukemia in the region of Annaba, in the east of Algeria. Description of the epidemiological, clinical and cytological characteristics of the cases of acute leukemia collected in the Hematology Laboratory of Dorban Hospital over a period of 6 years. - Analysis of the results of our study and their comparison with those published in the literature, with a reminder of the epidemiological and diagnostic data. The retrospective study was conducted in the division of the hematology hospital of Sidi Ammar-Annaba, during the period from January 2018 to July 2019. This study was based on data from 50 patients. During our study period, the results show that 50 cases of acute leukemia confirmed by the myelogram were notified. The annual average is 12.3 cases. The collection data were made in Annaba at the CHU-Dorban, we noted a variety of clinical signs and a variety of symptoms represented mainly by fever (100%), anemia (100%), hemorrhagic syndromes (30 , 6%) and splenomegaly (80.6%). For the myelogram. Acute lymphoblastic leukemia (ALL) was predominant with 25 cases. In conclusion we can say that. Acute leukemia in adults in eastern Algeria can be expressed by a variety of symptoms and hematological disorders, in addition to a series of associated conditions.
[1] Haferlach T, Kern W, Schnittger S, Schoch C. Modern diagnostics in acute leukemias. Crit Rev Oncol Hematol. 2005;56(2):223–34.
[2] Valensia F. Classification des leucémies aiguës. Apport des propositions de l’Organisation mondiale de la santé. Encyclopédie Médico-Chirurgicale.2003. p. 13-18-NaN-5.
[3] Hiddemann W, M.Fiegl, W.Hiddemann, K.Metzeler, K.Spiekermann MS. Handbook oAcut Leukemia. Hiddemann W, editor. Munich: Springer International Publishing; 2016.
[4] Lacour B, Guyot-Goubin A, Guissou S, Bellec S, Désandes E, Clavel J. Incidence of childhood cancer in France: National Children Cancer Registries, 2000–2004. Eur J Cancer Prev. 2010;19(3):173–81.
[5] Maynadié M, Troussard X. Epidémiologie des leucémies aigues. Rev Francoph des Lab ;2015(471):29–33.
[6] Bennett JM, Catovsky D, Daniel M ‐T, Flandrin G, Galton DAG, Gralnick HR, et al. Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative Group. Br J Haematol. 1976;33(4):451–8.
[7] Costopoulos M, Garff-tavernier M Le. Immunophénotypage des hémopathies malignes par cytométrie en flux. EMC- Hématologie. 2016;11(16):1–16.
[8] Duployez N, Preudhomme C. Place de la biologie moléculaire pour le diagnostic et le suivi de leucémies aiguës. Rev Francoph des Lab . 2015;2015(471):51–64.
[9] Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells.
Nature. 2001;414(6859):105–11.
[10] Imbert M, Wagner-Ballon O. Place du biologiste dans la prise en charge des leucémies aigues: de l’hémogramme à la classification OMS. Rev Francoph des Lab. 2015;2015(471):83–90.
[11] Brette D, Monteil J. Manifestations oto-rhino-laryngologiques des hémopathies de l’adulte. EMC - Oto-rhino-laryngologie. 2005;1(1):56–72.
[12] Linet MS, Dores GM, Kim CJ, Devesa SS, Morton LM. Epidemiology and Hereditary Aspects of Acute Leukemia. Neoplastic Diseases of the Blood . Springer New York; 2013. p. 199–212.
[13] Troussard X, Duchenet V, Cornet E, Mouchel D, Malet M, Collignon A. Hematological malignancies: Incidence in Basse-Normandie, France, for 1997-2004. Rev Epidemiol Sante Publique.2009;57(3).
[14] Nafil H, Tazi I, Faez S, Benchemsi N. Profil cytologique des leucémies aigues à Casablanca. J Africain du Cancer. 2012;4(2):79–83.
[15] RHAFEL A. Bilan d’activité du service d’Hématologie du CHU Mohammed VI 2009-2013. UNIVERSITE CADI AYYAD; 2014.
[16] Rego MFN, Pinheiro GS, Metze K, Lorand-Metze I. Acute leukemias in Piaui: Comparison with features observed in other regions of Brazil. Brazilian J Med Biol Res. 2003;36(3):331–7.
[17] Forman D, Stockton D, Møller H, Quinn M, Babb P, De Angelis R, et al. Cancer prevalence in the UK: Results from the EUROPREVAL study. Ann Oncol. 2003;14(4):648–54.
[18] Altekruse S, Kosar C, Krapcho M, Neyman N, Aminou R, Waldron W, et al. SEER Cancer Statistics Review (1975-2007) . Vol. Bethesda, National Cancer Institute. (2010). Available from: http://seer.cancer.gov/csr/1975_2010/ based on November 2012 SEER data submission, posted to the SEER web site, April 2013.
[19] Longo DL, Hunger SP, Mullighan CG. Acute Lymphoblastic Leukemia in Children. N Engl J Med . 2015;373(16):1541–52.
[20] Jmili NB, Aziz ABA, Nagara M, Mahjoub T, Ghannem H, Mondher K. Profil épidémiologique et cytologique des leucémies aigués : à propos de 193 cas colligés au centre Tunisien. Rev Française des Lab . 2005 Jan; 2005 ; (369):23–8.
[21] Harioly Nirina MOM, Rakotoarivelo ZL, Ntoezara A, Rasolonjatovo AS, RakotoAlson AO. Épidémiologie et diagnostic des leucémies aiguës à l’hôpital Ravoahangy Andrianavalona Antananarivo Madagascar. J Africain du Cancer / African J Cancer . 2015 Nov 22;7(4):186 9.
[22] Raidelet L. Epidémiologie des leucémies de patients dromois et ardechois diagnostiquées au centre hospitalier de valence de 2005-2010. Université Joseph Fourier ; (2011).
[23] Moppett J, Dommett R. Childhood Acute Lymphoblastic Leukemia : Clinical Presentation and Prognostic Factors. Springer International Publishing; 2017, p. 29–48..
[24] Braham-Jmili N, Sendi-Senana H, Khelif A, Saad A. Leucémies aigues myéloides en Tunisie : Caractéristiques épidémiologiques et cliniques et classification OMS. J Africain du Cancer. 2010;2(1):25–32.
[25] Sintha M, Muthuraman M. A retrospective study of clinical and laboratory parameter of acute leukaemias. MedPulse – Int Med J. 2016;3(May):542–6.
| Files | ||
| Issue | Vol 58, No 10 (2020) | |
| Section | Original Article(s) | |
| DOI | https://doi.org/10.18502/acta.v58i10.4914 | |
| Keywords | ||
| Leukemias Acute lymphoblastic leukemia (ALL) Acute myeloid leukemia (AML) Lymphocytes Myelogram | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
